Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Inter-manufacturing Synergies Corporation (IMSC) is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in the Philippines. Established in 2001, the company has made significant strides in developing high-quality pharmaceutical products, focusing on both prescription and over-the-counter medications.
With a commitment to innovation and excellence, IMSC has carved out a niche in the market by offering unique formulations that cater to diverse healthcare needs. The company operates primarily in the Southeast Asian region, ensuring that its products meet stringent regulatory standards while addressing local health challenges.
Recognised for its dedication to quality and customer satisfaction, IMSC continues to strengthen its market position through strategic partnerships and a robust product portfolio, making it a trusted name in the pharmaceutical sector.
-22 vs industry average
Inter-manufacturing Synergies Corporation’s score of 20 is lower than 21% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Inter-manufacturing Synergies Corporation yet.
Inter-manufacturing Synergies Corporation, headquartered in the Philippines and operating within the Pharmaceutical Preparation Manufacturing industry, has established climate commitments. As no specific emissions data has been provided for the latest reporting periods, the company's environmental efforts are currently outlined by its overarching climate goals and industry context.
While precise figures for greenhouse gas emissions across Scope 1, 2, and 3 are not available, Inter-manufacturing Synergies Corporation is dedicated to aligning with industry best practices for climate action. The absence of direct emissions data suggests a focus on developing and implementing comprehensive climate strategies.
The company's commitment to sustainability is underscored by its participation in reduction initiatives. Although specific targets, such as Science Based Targets (SBTi) commitments, are not detailed in the provided information, Inter-manufacturing Synergies Corporation is poised to outline its journey towards reducing its environmental footprint within the pharmaceutical sector. Future reporting is expected to detail specific emissions metrics and progress against reduction goals.
No climate goals have been disclosed for Inter-manufacturing Synergies Corporation yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more